FDA Approves First Anti-Diarrheal Drug for HIV/AIDS Patients
The US Food and Drug Administration today approved Fulyzaq ( crofelemer ) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection. Diarrhea is experienced by many HIV/AIDS patients and is a common reason why patients discontinue or switch their antiretroviral therapies. Fulyzaq is intended to be used in HIV/AIDS patients whose diarrhea is not caused by an infection from a virus, bacteria, or parasite. Patients take Fulyzaq two times a day to manage watery diarrhea due to the secretion of electrolytes ...
Using Opium Painkillers to Treat Stomach Pain
Many Americans battle chronic abdominal pain, which may be a symptom of serious conditions such as irritable bowel syndrome, colitis, or gallstones. However, experts are worried that doctors are over-prescribing opioid painkillers for the pain, especially if another medication is a better option.
Vaccine for Kids Rocks
Rotavirus can happen to anyone, but is most dangerous for infants and the elderly. A vaccine is now available for young children between the ages of 6 and 12 weeks.
FDA approves treatment for Clostridium difficile infection
The U.S. Food and Drug Administration today approved Dificid ( fidaxomicin ) tablets for the treatment of Clostridium difficile-associated diarrhea ( CDAD ).
New Test Detecting Diarrhea-Causing Infection
The FDA has approved a test that detects an infection that causes diarrhea, other intestinal problems and sometimes death.